Status:
UNKNOWN
Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
Conditions:
Infertility
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
Estradiol valerate in the form of cycloprogenova™ (white tablet only) was started on day 2 or 3 of cycle with oral dose 4 mg divided on 2 doses in addition to Aspocid 75 mg once daily with folic acid ...
Detailed Description
U/S was done on day 9 or 10 of cycle to assess endometrial thickness, then every other day until endometrial thickness of 8 mm or more is reached and when endometrial thickness reaches 8 mm or more FE...
Eligibility Criteria
Inclusion
- PCOS patients according to Rotterdam criteria
- Female age between 20 and 40 years.
- Primary or secondary infertility.
- Body mass index (BMI) between 18 and 40 kg/m2.
Exclusion
- Ovarian endometriosis.
- Ovarian cysts before induction.
- Known uncontrolled endocrinal abnormalities (like hypo or hyperthyroidism)
Key Trial Info
Start Date :
February 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04749979
Start Date
February 5 2021
End Date
July 1 2021
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aljazeera( Al Gazeera) hospital
Giza, Egypt